» Articles » PMID: 12667235

Laboratory Diagnosis of Mycoplasma Pneumoniae Infection

Overview
Publisher Elsevier
Date 2003 Apr 2
PMID 12667235
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Diagnosis of Mycoplasma pneumoniae infection is challenging due to the fastidious nature of the pathogen, the considerable seroprevalence, and the possibility of transient asymptomatic carriage. During recent years, various new techniques have been adapted for the diagnosis of M. pneumoniae infection, notably in the field of molecular biology. Standard polymerase chain reaction (PCR) is currently the method of choice for direct pathogen detection, but several PCR-related methods provide enhanced sensitivity or more convenient handling procedures, and have been successfully applied for research purposes. Among these techniques are real-time PCR, nested PCR, reverse transcriptase PCR (RT-PCR) and multiplex PCR. Generally, amplification-based methods have replaced hybridization assays and direct antigen detection. Serology, which is the basic strategy for mycoplasma diagnosis in routine clinical practice, has been improved by the widespread availability of sensitive assays for separate detection of different antibody classes. For the diagnosis of mycoplasma pneumonia, serology and direct pathogen detection should be combined. Extrapulmonary diseases may be diagnosed by direct pathogen detection alone, but the value of this diagnostic approach is limited by the probably immunologically mediated pathogenesis of some manifestations. This review summarizes the current state of Mycoplasma pneumoniae diagnosis, with special reference to molecular techniques. The value of different methods for routine diagnosis and research purposes is discussed.

Citing Articles

Antibiotic resistance and viral co-infection in children diagnosed with pneumonia caused by Mycoplasma pneumoniae admitted to Russian hospitals during October 2023-February 2024.

Korneenko E, Rog I, Chudinov I, Lukina-Gronskaya A, Kozyreva A, Belyaletdinova I BMC Infect Dis. 2025; 25(1):363.

PMID: 40089690 DOI: 10.1186/s12879-025-10712-0.


Comparison of the epidemiological characteristics of mycoplasma pneumoniae infections among children during two epidemics in Wuhan from 2018 to 2024.

Mao J, Niu Z, Liu M, Li L, Zhang H, Li R BMC Pediatr. 2025; 25(1):71.

PMID: 39875866 PMC: 11773782. DOI: 10.1186/s12887-025-05435-9.


A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment.

Viz-Lasheras S, Gomez-Carballa A, Bello X, Rivero-Calle I, Dacosta A, Kaforou M Nat Commun. 2025; 16(1):673.

PMID: 39809748 PMC: 11733158. DOI: 10.1038/s41467-025-55932-9.


Evaluation of three rapid assays for detecting Mycoplasma pneumoniae in nasopharyngeal specimens.

Yang C, Wang Z, Kong L, Du J, Yi J AMB Express. 2024; 14(1):134.

PMID: 39694968 PMC: 11655899. DOI: 10.1186/s13568-024-01782-5.


An Atypical Presentation of Mycoplasma pneumoniae Infection Mimicking Acute Surgical Abdomen in an Adult.

Lim J, Wenham T Cureus. 2024; 16(11):e73665.

PMID: 39552739 PMC: 11565626. DOI: 10.7759/cureus.73665.